Scientific publications

Nature Communications, 2022

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Damsky W., Wang A., Kim D. et al.

Communications Biology, 2022

Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort

Yang J., Jia Z., Song X. et al.

Frontiers in Neurology, 2022

Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle B., Kitchen R., Mattingly Z. et al.

Nature Medicine, 2022

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Padrón L., Maurer D., O’Hara M. et al.

BMC Women's Health, 2022

Applicability of polygenic risk scores in endometriosis clinical presentation

Svensson A., Garcia-Etxebarria K., Åkesson A. et al.

Brain, 2022

A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease

Bottigliengo D., Foco L., Seibler P. et al.

Kidney Medicine, 2022

Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Scandinavian Journal of Immunology, 2022

The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Nature Communications, 2022

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Liu J., Wang Y., Tian Z. et al.

Journal of the American College of Cardiology, 2022

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data

Tayal U., Verdonschot J., Hazebroek M. et al.

Annals of Oncology, 2022

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Bessede A., Marabelle A., Guégan J. et al.

Multiple Sclerosis and Related Disorders, 2022

Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL

Gawde S., Agasing A., Bhatt N. et al.

Atherosclerosis, 2022

Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

Shafi B., Bøttcher M., Ejupi A. et al.

Molecular Psychiatry, 2022

Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

Mätlik K., Garton D., Montaño-Rodríguez A. et al.

Annals of the Rheumatic Diseases, 2022

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

Dörner T., Tanaka Y., Dow E. et al.

Osteoporosis International, 2022

Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

Sköld C., Kultima K., Freyhult E. et al.

Thorax, 2022

Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant

Heydarian M., Oak P., Zhang X. et al.

PLOS ONE, 2022

Genetically regulated gene expression and proteins revealed discordant effects

Pott J., Garcia T., Hauck S. et al.

PROTEOMICS, 2022

Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms

Haslam D., Li J., Dillon S. et al.

eBioMedicine, 2022

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones D., Wetten A., Barron-Millar B. et al.